MillerWL. The adrenal cortex and its disorder. In: BrookCGHindmarshPC, eds. Clinical Pediatric Endocrinology. 4th ed.Oxford, England: Blackwell Science; 2001:321-376.
2.
TemparkTPhatarakijnirundVChatproedpraiSWatcharasindhuSSupornsilchaiVWananukulS. Exogenous Cushing’s syndrome due to topical corticosteroid application: case report and review literature. Endocrine. 2010;38:328-334.
3.
FindlayCAMacdonaldJFWallaceAMGeddesNDonaldsonMD. Childhood Cushing’s syndrome induced by betamethasone nose drops, and repeat prescriptions. BMJ. 1998;317:739-740.
4.
MalozowskiSPuruckerMWorobecA. Cushing’s syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroid should be monitored for growth retardation. BMJ. 1999;318:1355.
5.
StewartPMKroneNP. The adrenal cortex. In: MelmedSPolonskyKSLarsenPRKronenbergHM, eds. Williams Text Book of Endocrinology. 12th ed.Philadelphia, PA: Saunders Elsevier; 2011:479-544.
6.
DecaniSFederighiVBaruzziESardellaALodiG. Iatrogenic Cushing’s syndrome and topical steroid therapy: case series and review of the literature. J Dermatol Treat. 2014;25:495-500.
7.
MelbyJC. Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations. Ann Intern Med. 1974;81:505-512.
8.
MichelsMISmithREHeminbidEM. Adrenal suppression and intranasally applied steroids. Ann Allergy. 1967;25:569-574.
9.
DuttaDShivaprasadKSGhoshSMukhopadhyaySChowdhuryS. Iatrogenic Cushing’s syndrome following short-term intranasal steroid use. J Clin Res Pediatr Endocrinol. 2012;4:157-159.
10.
DerendorfHMeltzerEO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63: 1292-1300.
